Date,Title,Source
"Mon, 08 Dec 2025 17:16:13 GMT",Regeneron’s (REGN) Recovery and Dupixent Strength Support BMO’s Outperform Rating - Insider Monkey,Insider Monkey
"Mon, 08 Dec 2025 02:53:10 GMT",Regeneron (REGN) Showcases Promising Trial Data for Lynozyfic in Multiple Myeloma - GuruFocus,GuruFocus
"Mon, 08 Dec 2025 13:30:43 GMT","Natixis Purchases 2,751 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat",MarketBeat
"Sun, 07 Dec 2025 12:06:04 GMT","Federated Hermes Inc. Acquires 204,045 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat",MarketBeat
"Sat, 06 Dec 2025 09:31:47 GMT","First Trust Advisors LP Increases Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat",MarketBeat
"Fri, 05 Dec 2025 19:17:19 GMT",Canaccord Genuity Group Forecasts Strong Price Appreciation for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock - MarketBeat,MarketBeat
"Fri, 05 Dec 2025 12:50:31 GMT","Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Guggenheim Capital LLC - MarketBeat",MarketBeat
"Fri, 05 Dec 2025 12:20:27 GMT","Invesco Ltd. Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat",MarketBeat
"Fri, 05 Dec 2025 14:28:03 GMT",BMO Capital Markets Issues Positive Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price - MarketBeat,MarketBeat
"Fri, 05 Dec 2025 10:11:43 GMT","Dodge & Cox Acquires 1,502,198 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat",MarketBeat
2025-12-10T13:42:51,"Regeneron Pharmaceuticals, Inc. (REGN) Discusses Lynozyfic Development Strategy and Pipeline Opportunities in Multiple Myeloma Transcript",SeekingAlpha
2025-12-02T20:42:00+00:00,REGN & Tessera Collaborate to Develop Gene-Editing Therapy for AATD,Yahoo Finance
